Corthera Report issue

For profit Phase 2 Phase 3
Founded: San Carlos CA United States (2003)
Status: Acquired by Novartis (2009)

Organization Overview

First Clinical Trial
2005
NCT00259103
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

relaxin (4 trials)

Drugs in Phase 2 Trials (1)

serelaxin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eclampsia (Phase 1)

Heart Failure (Phase 3)

Pre-Eclampsia (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 2